The EU has announced €6.4 billion ($8.3 billion) in funding this year for the Seventh Framework Program (FP7), marking a 12% increase over last year’s funding. It is estimated that 16,000 grants will be awarded. Among the areas designated to receive funding are health, which will receive €600 million, including €206 million for clinical trials, […]
In an effort to stimulate the economy, cut drug costs and reduce the dependence on imports, Russia has made its pharmaceutical industry a priority for modernization. The Pharma 2020 strategy aims to increase the percentage of medicines made in Russia from 23% to more than 50% over a 10-year period. Based on the strategy, a […]
The FDA intends to more tightly regulate direct-to-consumer (DTC) genetic tests. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, told Congress that the FDA will create a “draft oversight framework” for laboratory-developed tests (LDTs), a category that has up to now included DTC gene tests. LDTs are tests created and performed […]
The world’s 50 largest chemical producers generated total revenues of $697 billion last year. Sales fell 21.0% as the recession hurt demand and pricing. Only four companies among the top 50 posted revenue increases: LG Chemical, Reliance Industries, Mosaic and Sasol. Operating profits for the 46 companies that disclosed them declined 6.2% to $49 billion. […]
Oncologics were the top-selling class of therapeutics last year, with sales of $52.37 billion, followed by lipid regulators and respiratory agents, according to IMS. Autoimmune agents posted the fastest annual growth rate in 2009 among the top 15 therapeutic classes. Sales of autoimmune agents increased 18.0% to $13.75 billion, making them the 11th largest therapeutic […]
In July, the Dow Jones Industrial Average enjoyed its largest one month gain in a year, climbing 7.1%. The S&P 500 and NASDAQ each gained 6.9%. Initial earnings optimism from the financial sector coupled with a modest dip in the unemployment rate from 9.7% to 9.5% sent the Dow, S&P 500 and NASDAQ each up […]
Ulm, Germany 7/28/10—WITec GmbH, a provider of optical and scanning probe microscopes, has announced the purchase of a majority stake in omt – optische messtechnik gmbh. Omt supplies optical metrology tools, such as reflectometers, spectral ellipsometers and spectrometers, specializing in industrial applications, including process control. “Our goal is the extension of our market-leading position in […]
Cincinnati, OH 7/20/10—Life science company Meridian Bioscience has acquired all the outstanding capital stock of the Bioline group of companies for $23.3 million in cash. Headquartered in the UK, Bioline is a manufacturer and distributor of molecular biology reagents, including nucleotides and DNA polymerase enzymes. Bioline’s 2010 revenues are estimated to exceed $12 million. “Bioline […]
San Diego, CA 7/27/10—Ilumina has announced that it completed the purchase of Helixis on April 30 for $70 million in cash and up to $35 million in contingent consideration. Helixis is the developer of a high-performance, low-cost real-time PCR system. Illumina will begin selling the system, the Eco, in August for a list price of […]
The American Association for Clinical Chemistry (AACC) held its 61st annual meeting and exposition in Anaheim, California, from July 25 to July 29. Attendance figures were not available from the AACC prior to publication. With over 9,000 members, the AACC is the leading US organization for clinical lab professionals. The exhibition hall was busy on […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
